NU 3056
Latest Information Update: 10 Sep 1998
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Pyrimidines
- Mechanism of Action Nucleoside transport protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Sep 1998 Profile reviewed
- 10 Sep 1998 No-Development-Reported for Cancer in United Kingdom (Unknown route)
- 01 Oct 1996 Preclinical development for Cancer in United Kingdom (Unknown route)